DiaCarta, Inc. | Translational Genomics and Personalized Diagnostics Company
At DiaCarta, our mission is to improve the lives of cancer patients through innovative precision diagnostics. We are committed to providing accurate, reliable, and affordable diagnostics that help physicians make informed treatment decisions. Patient-Centric operations: Our mission is to provide innovative and affordable solutions for cancer patient management, and we prioritize the needs of patients and their families in everything we do. Innovation: We are committed to advancing precision diagnostics and improving patient outcomes through cutting-edge research and development. Continuous Improvement: We are dedicated to ongoing improvement and innovation, and we invest in the development of our team, our products, and our infrastructure to better serve our customers and achieve our mission. We are committed to designing and manufacturing products with the good of the patient in mind. DiaCarta’s RadTox™ Test to Monitor Tumor Response Receives Medicare Coverage. DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience.
This company is:
Verified
COVID-19 Testing CLIA Lab Service | DiaCarta, Inc.
CLIA Lab Service for COVID-19 Diagnostics | Service Highlights | Sample Collection Kits Available | FDA EUA Approved Test | COVID-19 Hotline | For Client: Collect Sample, Test & Receive Test Results | Step 1 | Step 2 | Step 3 | Step 4 | Step 5 | Test Process within DiaCarta – Quality Results within 48 hours | Step 1 | Step 2 | Step 3 | Step 4 | Step 5 | Step 6 | COVID-19 Total Solution | QuantiVirus™ SARS-CoV-2 Test Kit (Detects 3 genes) | QuantiVirus™ SARS-CoV-2 Multiplex Test Kit (Detects 1 gene) | QuantiVirus™ Anti-SARS-CoV-2 IgG Test Kit | CLIA Lab COVID-19 Diagnostics Service | Nasal Sample Collection Kit for COVID-19 | Saliva Sample Collection Kit for COVID-19 | Need Help? | Ready to Subscribe and Learn? | You have Successfully Subscribed!
Verified
QuantiVirus™ SARS-CoV-2/FluA&B Antigen Rapid Test | DiaCarta, Inc.
QuantiVirus™ SARS-CoV-2/FluA&B Antigen Rapid Test | Self-Test with Simple Nasal Swab | Introducing the QuantiVirus™ SARS-CoV-2/FluA&B Antigen Rapid Test | COVID-19 Total Solution | QuantiVirus™ SARS-CoV-2 Test Kit (RT-PCR Test - Detects 3 genes) | QuantiVirus™ SARS-CoV-2 Multiplex Test Kit (RT-PCR Test - Detects 1 gene) | QuantiVirus™ Anti-SARS-CoV-2 IgG Test Kit (Antibody Test - Research Use Only) | COVID-19 Clinical Laboratory Testing Service
Verified
Dimerator™ Adapter Dimer Removal | DiaCarta, Inc.
Dimerator™ Adapter Dimer Removal for NGS Library Preparation | Increase valuable sequencing reads | Increase valuable sequencing reads | Handle low inputs and small RNA (e.g. miRNA) | Tag samples with low target abundance efficiently | Full automation possible | Adapter Dimer Removal for NGS Library Preparation | Traditional Methods for Adapter Dimer Removal | Magnetic Beads Binding: takes time and performance varies depending on the vendors | Gel Purification: time consuming with possible sample loss | Adapter: target ratio optimization: helps but does not solve problems and may waste sample | Changing Adapter Design to Reduce Dimer Formation: helps but does not completely solve the problem | How Does Dimerator™ Adapter Dimer Removal Work? | Product Specifications for Dimerator™ Adapter Dimer Removal Test
View all products
Keywords
Industries
DiaCarta Demos Liquid Biopsy Use for ColoScape Assay, Plans to Market Expanded Application | DiaCarta, Inc.
DiaCarta Demos Liquid Biopsy Use for ColoScape Assay, Plans to Market Expanded Application | Dealing with the Respiratory Viruses that Cause Covid-19 or Flu | Early Cancer Detection Will Save More Lives | Assay Detects Precancerous Colorectal Cancer Lesions & Mutations | DiaCarta Positioning Liquid Biopsy Assay to Gauge Chemotherapy Response in Multiple Cancers | KRAS Codon 12 Mutations and Detection | HPV-driven Cancers and Somatic Mutations in These Cancers
City: Hayward
State: California
Country: United States
Where is DiaCarta located?
The company DiaCarta is located in Hayward, California, United States. It's worth noting that the company may has more corporate locations
How many employees does DiaCarta approximately have?
As of the latest available information DiaCarta has around 11-50 employees worldwide.
When was DiaCarta founded?
DiaCarta was founded in 2011
In which industries does DiaCarta mainly work?
The company DiaCarta has it's main focus in the industries of Biotechnology, Science and Engineering, Health Care
Datar Cancer Genetics Limited
India
51-100 Employees
Caris Life Sciences
United States
1001-5000 Employees
1996
Sterling Pathology National Laboratories
United States
11-50 Employees
2003
CareDx
United States
101-250 Employees
2000
Universal Diagnostics
Spain
11-50 Employees
2012
Qcdx LLC
United States
1-10 Employees
2016
Discovery Life Sciences
United States
11-50 Employees
2018
SAGA Diagnostics
Sweden
11-50 Employees
2016
Topics which have been searched by others and may be interesting for you:
